Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 17, 2025
SAMHD1
is
a
dNTPase
that
impedes
replication
of
HIV-1
in
myeloid
cells
and
resting
T
lymphocytes.
Here
we
elucidate
the
substrate
activation
mechanism
SAMHD1,
which
involves
dNTP
binding
at
allosteric
sites
transient
tetramerization.
Our
findings
reveal
tetramerization
alone
insufficient
to
promote
hydrolysis;
instead,
requires
an
inactive
tetrameric
intermediate
with
partially
occupied
sites.
The
equilibrium
between
active
states
regulates
activity,
driven
by
dissociation
additional
ligands
preassembled
tetramer.
Furthermore,
catalytic
efficiency,
but
not
specificity,
modulated
identity
dNTPs
occupying
We
show
how
this
regulation
shapes
deoxynucleotide
homeostasis
balancing
production
SAMHD1-catalyzed
depletion.
Notably,
exhibits
distinct
functionality,
term
facilitated
depletion,
whereby
increased
biosynthesis
certain
enhances
depletion
others.
regulatory
relationship
different
sheds
light
on
emerging
role
biology
implications
for
HIV/AIDS,
innate
antiviral
immunity,
cell
disorders,
telomere
maintenance
therapeutic
efficacy
nucleoside
analogs.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Ноя. 7, 2022
Abstract
Sterile
alpha
motif
and
HD
domain-containing
protein
1
(SAMHD1)
has
a
dNTPase-independent
function
in
promoting
DNA
end
resection
to
facilitate
double-strand
break
(DSB)
repair
by
homologous
recombination
(HR);
however,
it
is
not
known
if
upstream
signaling
events
govern
this
activity.
Here,
we
show
that
SAMHD1
deacetylated
the
SIRT1
sirtuin
deacetylase,
facilitating
its
binding
with
ssDNA
at
DSBs,
promote
HR.
complexes
deacetylates
conserved
lysine
354
(K354)
specifically
response
DSBs.
K354
deacetylation
promotes
HR
but
tetramerization
or
dNTPase
Mechanistically,
recruitment
DSBs
which
turn
facilitates
CtIP
binding,
leading
promotion
of
genome
integrity.
These
findings
define
mechanism
governing
stability.
Disease Models & Mechanisms,
Год журнала:
2024,
Номер
17(8)
Опубликована: Авг. 1, 2024
ABSTRACT
The
size
and
composition
of
the
intracellular
DNA
precursor
pool
is
integral
to
maintenance
genome
stability,
this
relationship
fundamental
our
understanding
cancer.
Key
aspects
carcinogenesis,
including
elevated
mutation
rates
induction
certain
types
damage
in
cancer
cells,
can
be
linked
disturbances
deoxynucleoside
triphosphate
(dNTP)
pools.
Furthermore,
approaches
treat
heavily
exploit
metabolic
interplay
between
dNTP
pool,
with
a
long-standing
example
being
use
antimetabolite-based
therapies,
strategy
continues
show
promise
development
new
targeted
therapies.
In
Review,
we
compile
current
knowledge
on
both
causes
consequences
perturbations
together
their
impact
stability.
We
outline
several
outstanding
questions
remaining
field,
such
as
role
catabolism
stability
expansion.
Importantly,
detail
how
mechanistic
these
processes
utilised
aim
providing
better
informed
treatment
options
patients
Journal of Translational Medicine,
Год журнала:
2022,
Номер
20(1)
Опубликована: Дек. 29, 2022
Abstract
Background
Sterile
alpha
motif
domain
and
histidine-aspartate
domain-containing
protein
1
(SAMHD1)
is
a
DNA
end
resection
factor,
which
involved
in
damage
repair
innate
immunity.
However,
the
role
of
SAMHD1
anti-tumor
immunity
still
unknown.
This
study
investigated
effects
on
stimulator
interferon
genes
(STING)-type
I
(IFN)
pathway
radiation-induced
immune
responses.
Methods
The
roles
activation
cytosolic
sensing
STING
lung
adenocarcinoma
(LUAD)
cells
were
with
flow
cytometry,
immunofluorescence,
immunoblotting
qPCR.
combined
silencing
radiation
tumor
cell
growth
also
evaluated
colony
formation
CCK8
assay.
Lewis
cancer
mouse
model
was
used
to
evaluate
efficiency
radiotherapy
vivo.
Macrophage
M1
polarization
cytotoxic
T
infiltration
cytometry.
Results
single-stranded
(ssDNA)
accumulated
cytosol
SAMHD1-deficient
cells,
accompanied
by
upregulated
sensor
IFN-γ-inducible
16
(IFI16)
activated
pathway.
translocation
IFI16
from
nucleus
detected
cells.
acquired
STING-IFN-I
LUAD
promoted
macrophage
vitro.
synergized
activate
ssDNA-STING-IFN-I
pathway,
inhibit
proliferation,
promote
apoptosis
regulate
cycle.
cooperated
increase
CD86
+
MHC-II
high
proportion
CD8
Conclusions
deficiency
induced
IFN-I
production
through
IFI16-STING
Moreover,
downregulation
enhance
responses
infiltration.
Combination
inhibition
may
be
potentially
therapeutic
strategy
for
patients.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Май 10, 2024
The
etiology
of
prostate
cancer,
the
second
most
common
cancer
in
men
globally,
has
a
strong
heritable
component.
While
rare
coding
germline
variants
several
genes
have
been
identified
as
risk
factors
from
candidate
gene
and
linkage
studies,
exome-wide
spectrum
causal
remains
to
be
fully
explored.
To
more
comprehensively
address
their
contribution,
we
analysed
data
37,184
cases
331,329
male
controls
five
cohorts
with
exome/genome
sequencing
one
cohort
imputed
array
population
enriched
low-frequency
deleterious
variants.
Our
gene-level
collapsing
analysis
revealed
that
damaging
Cancer Immunology Immunotherapy,
Год журнала:
2025,
Номер
74(3)
Опубликована: Фев. 1, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
has
an
immune-suppressive
tumor
microenvironment
that
contributes
to
resistance
immunotherapy.
This
study
aimed
demonstrate
elevated
sterile
alpha
motif
domain-containing
protein
3
(SAMD3)
expression
in
effector
CD8+
T
cells
was
associated
with
improved
survival
PDAC
patients.
We
investigated
the
heterogeneity
and
gene
profiles
of
using
a
single-cell
RNA
sequencing
(sc-RNA-seq)
dataset
comprised
human
samples.
SAMD3
mRNA
further
evaluated
tumor-specific
OT-I/ovalbumin
(OVA)
mouse
model.
levels
their
clinical
significance
were
via
immunohistochemistry
(IHC)
analysis.
highly
expressed
cytotoxic
cells,
significantly
downregulated
during
cell
exhaustion.
positively
correlated
function.
In
patients,
high
overall
(OS),
disease-free
(DFS),
infiltration.
A
patient
exhibiting
partial
response
combination
immunotherapy
also
showed
cells.
is
biomarker
function,
predicting
survival.
These
findings
highlight
potential
precision
approaches
for
treating
PDAC.
Archives of Physiology and Biochemistry,
Год журнала:
2025,
Номер
unknown, С. 1 - 10
Опубликована: Фев. 23, 2025
Introduction
This
study
aimed
to
assess
the
expression
changes
of
BTG1,
PGI,
and
PGII
in
tissues
serum
patients
with
gastric
cancer,
atrophic
gastritis,
healthy
individuals.